Tim Dall (The Lewin Group) Plamen Nikolov (Paul H Nitze School of Advanced International Studies - Johns Hopkins University) Paul Hogan (The Lewin Group)
Additional information is available for the following
registered author(s):
The study highlights the large and rising cost of the disease: an estimated $132 billion, or approximately $92 billion in direct healthcare expenditures and $40 billion in lost productivity attributed to missed workdays, disability, and early mortality. After adjusting for differences in demographics between the two populations, the study finds that people with diabetes incur healthcare costs approximately 2.4 times higher than people without diabetes. One- third of the approximately 17 million people in the U.S. with diabetes remain undiagnosed, $132 billion represents a conservative estimate. Moreover, the prevalence of type 2 diabetes increases with age and is higher among certain racial and ethnic minority populations, which portends a substantial increase in incidence of the disease (and its associated costs) as the nation grows older and becomes more racially and ethnically diverse.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Publisher Info
Paper provided by EconWPA in its series HEW with number
0306001.
Find related papers by JEL classification: I10 - Health, Education, and Welfare - - Health - - - General I12 - Health, Education, and Welfare - - Health - - - Health Production I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health I19 - Health, Education, and Welfare - - Health - - - Other
This paper has been announced in the following NEP Reports: